688505 复旦张江
已收盘 07-18 15:00:01
资讯
新帖
简况
XD复旦张下跌5.11% 成长股分化资金撤离
智选洞察 · 07-18 01:50
XD复旦张下跌5.11% 成长股分化资金撤离
复旦张江(01349)股东杨宗孟、王海波合计减持公司1.41%股权
智通财经 · 07-17
复旦张江(01349)股东杨宗孟、王海波合计减持公司1.41%股权
体外诊断概念盘中拉升,复旦张江涨12.17%
市场透视 · 07-17
体外诊断概念盘中拉升,复旦张江涨12.17%
港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行
智通财经 · 07-17
港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行
复旦张江涨5.37%创近8个月新高 创新药管线进展提振股价
智选洞察 · 07-17
复旦张江涨5.37%创近8个月新高 创新药管线进展提振股价
【私募调研记录】宁泉资产调研复旦张江
证券之星 · 07-16
【私募调研记录】宁泉资产调研复旦张江
复旦张江股东王海波减持427万股 持股比例降至5.00%
财中社 · 07-15
复旦张江股东王海波减持427万股 持股比例降至5.00%
复旦张江:有知名机构明汯投资参与的多家机构于7月9日调研我司
证券之星 · 07-15
复旦张江:有知名机构明汯投资参与的多家机构于7月9日调研我司
每周股票复盘:复旦张江(688505)认购0.9亿结构性存款及分红实施
证券之星 · 07-12
每周股票复盘:复旦张江(688505)认购0.9亿结构性存款及分红实施
复旦张江:2024年每股派发现金红利0.03元
公司公告 · 07-09
复旦张江:2024年每股派发现金红利0.03元
复旦张江(01349)认购总金额为0.90亿元的结构性存款产品
智通财经 · 07-07
复旦张江(01349)认购总金额为0.90亿元的结构性存款产品
复旦张江(01349)认购1.8亿元的结构性存款产品
智通财经 · 07-04
复旦张江(01349)认购1.8亿元的结构性存款产品
创新药板块逆势上行,机构称创新药为核心投资主线
每日经济新闻 · 07-04
创新药板块逆势上行,机构称创新药为核心投资主线
复旦张江(01349)认购2.1亿元结构性存款产品
智通财经网 · 07-02
复旦张江(01349)认购2.1亿元结构性存款产品
中国创新药能否持续让世界买单?券商分析师最新观点
券商中国 · 06-30
中国创新药能否持续让世界买单?券商分析师最新观点
复旦张江(01349):提名委员会委员变更
智通财经 · 06-30
复旦张江(01349):提名委员会委员变更
复旦张江:从空白到领跑,他们是光动力领域的“追光者”
金台资讯 · 06-30
复旦张江:从空白到领跑,他们是光动力领域的“追光者”
每周股票复盘:复旦张江(688505)股东减持与年度股东大会决议
证券之星 · 06-28
每周股票复盘:复旦张江(688505)股东减持与年度股东大会决议
复旦张江06月25日遭主力抛售424.7万元
市场透视 · 06-25
复旦张江06月25日遭主力抛售424.7万元
复旦张江获得发明专利授权:“一种伊喜替康衍生物的制备方法及其中间体”
证券之星企业动态 · 06-24
复旦张江获得发明专利授权:“一种伊喜替康衍生物的制备方法及其中间体”
加载更多
公司概况
公司名称:
上海复旦张江生物医药股份有限公司
所属行业:
医药制造业
上市日期:
2020-06-19
主营业务:
上海复旦张江生物医药股份有限公司的主营业务是生物医药的创新研究开发、生产制造和市场营销。公司的主要产品是盐酸氨酮戊酸外用散、注射用海姆泊芬、长循环盐酸多柔比星脂质体注射液。
发行价格:
8.95
{"stockData":{"symbol":"688505","market":"SH","secType":"STK","nameCN":"复旦张江","latestPrice":9.83,"timestamp":1752822001000,"preClose":10.18,"halted":0,"volume":37936617,"delay":0,"changeRate":-0.0344,"floatShares":711000000,"shares":1036999999,"eps":0.0387,"marketStatus":"已收盘","change":-0.35,"latestTime":"07-18 15:00:01","open":10.01,"high":10.01,"low":9.61,"amount":370000000,"amplitude":0.0393,"askPrice":9.83,"askSize":182,"bidPrice":9.82,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.0387,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.18,"symbolType":"stock_kcb","openAndCloseTimeList":[[1752802200000,1752809400000],[1752814800000,1752822000000]],"highLimit":11.2,"lowLimit":9.16,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1036572100,"isCdr":false,"pbRate":4.42,"roa":"--","peRate":254.005168,"roe":"0.12%","epsLYR":0.04,"committee":-0.211186,"marketValue":10190000000,"turnoverRate":0.0534,"status":1,"afterMarket":{"amount":1966,"volume":200,"close":9.83,"buyVolume":3049,"sellVolume":0,"time":1752824038022,"indexStatus":"已收盘 07-18 15:30:00","preClose":10.18},"hkstockBrief":{"symbol":"01349","market":"HK","secType":"STK","nameCN":"复旦张江","latestPrice":4.18,"timestamp":1752826113624,"preClose":4.4,"halted":0,"volume":52441000,"delay":0,"premium":"-61.09"},"floatMarketCap":6985000000},"requestUrl":"/m/hq/s/688505","defaultTab":"news","newsList":[{"id":"2552628453","title":"XD复旦张下跌5.11% 成长股分化资金撤离","url":"https://stock-news.laohu8.com/highlight/detail?id=2552628453","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552628453?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:50","pubTimestamp":1752803408,"startTime":"0","endTime":"0","summary":"07月18日,XD复旦张股价大幅下跌,最新价为9.66元/股,下跌5.11%。7月17日,医药生物、电子等行业占据新高股半数席位,资金从红利板块向成长赛道迁移的趋势强化。机构对成长股后市持审慎乐观态度。当前创业板指动态市盈率为66倍,处于近三年中枢水平,资金对业绩确定性要求或将提高。中原证券提示,需关注半年报业绩兑现情况,部分估值透支的标的可能面临分化压力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718095019a6b0e794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718095019a6b0e794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0},{"id":"2552483309","title":"复旦张江(01349)股东杨宗孟、王海波合计减持公司1.41%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2552483309","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552483309?lang=zh_cn&edition=full","pubTime":"2025-07-17 18:28","pubTimestamp":1752748105,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)公布,公司于近日收到杨宗孟先生、王海波先生出具的《关于股份减持计划实施情况的告知函》,杨宗孟先生于 2025 年 7 月 14 日至 2025 年 7 月 16 日期间通过集中竞价交易方式累计减持公司股份数量为 10,365,721 股,减持股份数量占公司总股本比例为 1.00%;王海波先生于 2025 年 7 月 14 日至 2025 年 7 月 15 日通过集中竞价交易方式累计减持公司股份数量 4,270,722 股,减持股份数量占公司总股本比例为 0.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK1191","BK0239","01349"],"gpt_icon":0},{"id":"2552055181","title":"体外诊断概念盘中拉升,复旦张江涨12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552055181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552055181?lang=zh_cn&edition=full","pubTime":"2025-07-17 14:17","pubTimestamp":1752733021,"startTime":"0","endTime":"0","summary":"07月17日,体外诊断概念盘中拉升,截至14点16分,体外诊断概念整体指数上涨1.01%,报1148.690点。从个股上来看,该概念的成分股中,复旦张江涨12.17%,塞力医疗涨幅超过5%。从资金上来看,截止发稿,体外诊断概念概念主力净流入为277.47万,其中塞力医疗受到资金热捧,主力净流入2.03亿;拉长时间线来看,该板块近20日主力资金净流入-27.47亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507171417029545c2c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507171417029545c2c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603716","01349","688505","BK0239"],"gpt_icon":0},{"id":"2552174909","title":"港股异动 | 复旦张江(01349)涨超12% ADC平台研发进展顺利 光动力平台项目加速进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2552174909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552174909?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:52","pubTimestamp":1752717129,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,复旦张江涨超12%,截至发稿,涨12.21%,报4.32港元,成交额2.45亿港元。消息面上,近日,复旦张江在投资者关系活动记录表中披露,公司ADC平台研发进展顺利。治疗三阴乳腺癌、膀胱癌、胃癌等多种肿瘤的抗Trop2抗体偶联药物已在ASCO官网发表了I期临床研究数据结果,针对TNBC适应症的III期临床研究正在进行中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK4080","BK4231","ADC","01349","BK1191","BK0239"],"gpt_icon":0},{"id":"2552318174","title":"复旦张江涨5.37%创近8个月新高 创新药管线进展提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2552318174","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552318174?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:33","pubTimestamp":1752716026,"startTime":"0","endTime":"0","summary":"复旦张江今日盘中表现强势,截至09点33分,股价报9.61元/股,涨幅达5.37%,创近8个月以来新高。估值博弈与技术突破共振下的资金分歧近期复旦张江股价波动与主力资金频繁调仓密切相关。AH股溢价率超185%的跨市场价差,进一步压制A股上行空间。创新药管线商业化进程决定价值中枢复旦张江长期逻辑仍取决于光动力药物管线的临床验证与商业化进展。当前4.27倍市净率虽低于部分创新药企,但需核心产品放量验证成长性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093624a6ae847a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717093624a6ae847a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505","159992"],"gpt_icon":0},{"id":"2551190276","title":"【私募调研记录】宁泉资产调研复旦张江","url":"https://stock-news.laohu8.com/highlight/detail?id=2551190276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551190276?lang=zh_cn&edition=full","pubTime":"2025-07-16 08:02","pubTimestamp":1752624131,"startTime":"0","endTime":"0","summary":"根据市场公开信息及7月15日披露的机构调研信息,知名私募宁泉资产近期对1家上市公司进行了调研,相关名单如下:1)复旦张江 调研纪要:复旦张江介绍了公司DC平台和光动力技术平台的研发进展。复美达主要受众为儿童,已完成IV期临床研究,未来拓展空间大。公司将继续加大研发投入,推动研发项目进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2025071600005547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688505","BK0239","BK1191","01349"],"gpt_icon":0},{"id":"2551161660","title":"复旦张江股东王海波减持427万股 持股比例降至5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551161660","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551161660?lang=zh_cn&edition=full","pubTime":"2025-07-15 19:12","pubTimestamp":1752577951,"startTime":"0","endTime":"0","summary":"复旦张江(688505/01349)发布公告,股东王海波在2025年7月14日至7月15日期间通过集中竞价交易减持公司股份427万股,减持后持股数量为5183万股,占公司总股本的比例降至5.00%。此次减持占公司总股本的比例为0.41%,王海波此前持有的股份为5610万股,占总股本的比例为5.41%。本次权益变动为王海波先生履行之前披露的减持计划,不触及要约收购。公司无控股股东和实际控制人,因此此次权益变动不会导致公司的控制权发生变化,也不会对公司治理结构及持续经营产生重大影响。2025年一季度,复旦张江实现收入1.80亿元,归母净利润267万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071519131297a6f534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071519131297a6f534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","688505","01349"],"gpt_icon":0},{"id":"2551505291","title":"复旦张江:有知名机构明汯投资参与的多家机构于7月9日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2551505291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551505291?lang=zh_cn&edition=full","pubTime":"2025-07-15 17:01","pubTimestamp":1752570080,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年7月15日复旦张江发布公告称汇添富基金、青骊投资、贝莱德、宁泉资产、财通基金、明汯投资、云阳宜品、申万财富、申万医药、平安证券、德邦基金、诺安基金、东吴基金、东方自营、兴证医药、中银基金、惠升基金、华泰保兴基金于2025年7月9日调研我司。目前,该项目用于治疗乳腺癌适应症的II期临床研究正在进行中,同时针对其他适应症的临床拓展亦在积极开展中。目前公司已完成该药物上市后的IV期临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071500028446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2551587914","title":"每周股票复盘:复旦张江(688505)认购0.9亿结构性存款及分红实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2551587914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551587914?lang=zh_cn&edition=full","pubTime":"2025-07-13 06:24","pubTimestamp":1752359051,"startTime":"0","endTime":"0","summary":"截至2025年7月11日收盘,复旦张江报收于9.16元,较上周的9.05元上涨1.22%。本周,复旦张江7月7日盘中最高价报9.29元。公司公告汇总复旦张江与招商银行订立结构性存款产品协议,本公司及全资附属公司泰州复旦张江合计以人民币0.90亿元的自有闲置资金认购招商银行结构性存款产品。该交易构成须予披露的交易,需遵守相关申报及公告规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071300001154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01349","688505","BK0239","BK1191"],"gpt_icon":0},{"id":"2550631270","title":"复旦张江:2024年每股派发现金红利0.03元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550631270","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550631270?lang=zh_cn&edition=full","pubTime":"2025-07-09 19:00","pubTimestamp":1752058826,"startTime":"0","endTime":"0","summary":"复旦张江公告,2024年年度权益分派实施每股现金红利0.03元(含税),股权登记日为2025年7月17日,除权(息)日和现金红利发放日均为2025年7月18日。本次利润分配以公司总股本103657.21万股为基数,共计派发现金红利3109.716万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190915a4403c64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709190915a4403c64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01349","BK0239","688505"],"gpt_icon":0},{"id":"2549844805","title":"复旦张江(01349)认购总金额为0.90亿元的结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2549844805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549844805?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:55","pubTimestamp":1751878541,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,近日,本公司与招商银行订立招商银行结构性存款产品协议 I,本公司的全资附属公司泰州复旦张江与招商银行订立招商银行结构性存款产品协议 II,本集团同意以日常营运产生的自有闲置资金向招商银行认购总金额为人民币0.90亿元的结构性存款产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01349","688505","BK0239"],"gpt_icon":0},{"id":"2548369029","title":"复旦张江(01349)认购1.8亿元的结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2548369029","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548369029?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:02","pubTimestamp":1751619762,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,近日,本公司与中国银行订立中国银行结构性存款产品协议,同意以A股公开发行所得暂时闲置募集资金向中国银行认购金额为人民币1.80亿元的结构性存款产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1314058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK0239","688505","01349"],"gpt_icon":0},{"id":"2548330540","title":"创新药板块逆势上行,机构称创新药为核心投资主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2548330540","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548330540?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:29","pubTimestamp":1751596152,"startTime":"0","endTime":"0","summary":"7月4日早盘,A股整体小幅回落,医药板块逆势上行,科创医药ETF基金涨幅超0.5%。公开信息显示,科创医药ETF基金跟踪上证科创板生物医药指数,囊括科创板中创新药、国产高端医疗设备、生命科学与生物技术等领域的专精特新公司。伴随政策对创新药保驾护航、创新药获批上市井喷、出海以及国产替代,医药行业有望迎来机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103134a4ce73ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704103134a4ce73ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688506","688520","159992","688331","688505","688091","688076","BK0239"],"gpt_icon":0},{"id":"2548861024","title":"复旦张江(01349)认购2.1亿元结构性存款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2548861024","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548861024?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:47","pubTimestamp":1751446026,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,近日,公司与浦发银行订立浦发银行结构性存款产品协议,同意以日常营运产生的自有闲置资金向浦发银行认购总金额为人民币2.10亿元的结构性存款产品。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","01349","BK1191","688505"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单?券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计,2025年1—5月,中国创新药企对外授权交易总金额已达455亿美元,超过2024年上半年的交易总额,创新药出海授权交易大爆发。亮眼数据的背后,是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力,正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期,年内大涨明显的创新药企业荣昌生物股价近期大幅回调,从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","601607","688136","06160","600200","600380","600222","603707","600332","600881","603998","688235","688278","688488","600062","600789","600196","600998","603456","600056","688202","688505","688520","ONC","688319","600216","688163","603590","688513","600851","600557","688317","688117","688131","603259","BK0239","688177","600420","600774","688331","688073","688181","688189","600721","600080","600682","603087","688336","600267","600351","600645","603716","688321","600079","688198","600422","600513","600276","688356","688091","600867","605199","603567","688506","159992","688068","601089","600535","603229","600521","603367","688166","688222","600572"],"gpt_icon":0},{"id":"2547939069","title":"复旦张江(01349):提名委员会委员变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2547939069","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547939069?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:00","pubTimestamp":1751274014,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复旦张江(01349)发布公告,公司第八届董事会提名委员会组成自2025年6月30日起变更为:由两名独立非执行董事(即徐培龙先生(主席)及林兆荣先生)及一名执行董事(即薛燕女士)组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688505","BK1191","01349","BK0239"],"gpt_icon":0},{"id":"2547003284","title":"复旦张江:从空白到领跑,他们是光动力领域的“追光者”","url":"https://stock-news.laohu8.com/highlight/detail?id=2547003284","media":"金台资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547003284?lang=zh_cn&edition=full","pubTime":"2025-06-30 09:55","pubTimestamp":1751248512,"startTime":"0","endTime":"0","summary":"人民网记者 唐小丽在光动力治疗领域的赛道上,有这样一群执着的“追光者”。如今,复旦张江相继成功研制艾拉光动力治疗尖锐湿疣和复美达光动力治疗鲜红斑痣,在迄今全世界已批准上市的十二种光动力药物中占据其二。2024年,复旦张江的复美达正式开启在美国的临床试验,标志着中国光动力药物开始走向国际舞台。在光动力这片充满希望的领域,这群“追光者”仍在不停奔跑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630095752a4c55dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630095752a4c55dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505","01349"],"gpt_icon":0},{"id":"2547704552","title":"每周股票复盘:复旦张江(688505)股东减持与年度股东大会决议","url":"https://stock-news.laohu8.com/highlight/detail?id=2547704552","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547704552?lang=zh_cn&edition=full","pubTime":"2025-06-29 07:39","pubTimestamp":1751153948,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,复旦张江报收于8.52元,较上周的8.38元上涨1.67%。本周,复旦张江6月25日盘中最高价报8.66元。复旦张江2024年度股东周年大会决议公告会议于2025年6月26日在上海市浦东新区碧波路699号上海博雅酒店一楼会议室召开,由董事会主席赵大君主持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900001344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01349","BK0239","688505","BK1191"],"gpt_icon":0},{"id":"2546218337","title":"复旦张江06月25日遭主力抛售424.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546218337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546218337?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836059,"startTime":"0","endTime":"0","summary":"06月25日, 复旦张江股价跌0.82%,报收8.50元,成交金额5016.8万元,换手率0.83%,振幅2.45%,量比0.83。复旦张江今日主力资金净流出424.7万元,连续7日净流出,上一交易日主力净流出584.1万元。该股近5个交易日下跌1.62%,主力资金累计净流出3198.6万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出7131.1万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171846a4bd0c51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171846a4bd0c51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688505","BK0239"],"gpt_icon":0},{"id":"2546301242","title":"复旦张江获得发明专利授权:“一种伊喜替康衍生物的制备方法及其中间体”","url":"https://stock-news.laohu8.com/highlight/detail?id=2546301242","media":"证券之星企业动态","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546301242?lang=zh_cn&edition=full","pubTime":"2025-06-25 02:51","pubTimestamp":1750791093,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示复旦张江新获得一项发明专利授权,专利名为“一种伊喜替康衍生物的制备方法及其中间体”,专利申请号为CN202180093750.6,授权日为2025年6月24日。今年以来复旦张江新获得专利授权9个,较去年同期增加了800%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625025342978d37de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625025342978d37de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688505"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753050992987,"stockEarnings":[{"period":"1week","weight":0.0762},{"period":"1month","weight":0.141},{"period":"3month","weight":0.318},{"period":"6month","weight":0.3394},{"period":"1year","weight":0.5212},{"period":"ytd","weight":0.2853}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0787},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.1872},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海复旦张江生物医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19104人(较上一季度增加0.29%)","perCapita":"37194股","listingDate":"2020-06-19","address":"上海市浦东新区张江高科技园区蔡伦路308号","registeredCapital":"10365万元","survey":" 上海复旦张江生物医药股份有限公司的主营业务是生物医药的创新研究开发、生产制造和市场营销。公司的主要产品是盐酸氨酮戊酸外用散、注射用海姆泊芬、长循环盐酸多柔比星脂质体注射液。","listedPrice":8.95},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复旦张江,688505,复旦张江股票,复旦张江股票老虎,复旦张江股票老虎国际,复旦张江行情,复旦张江股票行情,复旦张江股价,复旦张江股市,复旦张江股票价格,复旦张江股票交易,复旦张江股票购买,复旦张江股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复旦张江(688505)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复旦张江(688505)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}